FDA Approved: NYSTATIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for NYSTATIN from Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Oral Candidiasis

Drugs mentioned

• Nystatin (Nystatin)

Snippet

SUPPL AP for NYSTATIN (NYSTATIN)